Latest Articles
DUO-E Post Hoc Analysis Suggests Potential for Biomarker-Optimized pMMR Endometrial Cancer Management - OncLive
DUO-E Post Hoc Analysis Suggests Potential for Biomarker-Optimized pMMR Endometrial Cancer Management OncLive
Published: May 6, 2025, 2:01 p.m.
SERAM highlights use of MRI to diagnose endometriosis - AuntMinnieEurope
SERAM highlights use of MRI to diagnose endometriosis AuntMinnieEurope
Published: May 1, 2025, 12:45 p.m.
A Case Series: Activity of Pembro-Lenvatinib in dMMR EC Who Have Not Responded to Pembro-Mono - OncLive
A Case Series: Activity of Pembro-Lenvatinib in dMMR EC Who Have Not Responded to Pembro-Mono OncLive
Published: April 21, 2025, 1:17 p.m.
Subtle Medical inks deal with Strategic Radiology for MRI AI suite - AuntMinnie
Subtle Medical inks deal with Strategic Radiology for MRI AI suite AuntMinnie
Published: April 16, 2025, 9:10 p.m.
Deep learning boosts MRI's ability to identify endometriosis - AuntMinnie
Deep learning boosts MRI's ability to identify endometriosis AuntMinnie
Published: April 15, 2025, 9:48 p.m.
Dr Lee on the Preliminary Safety of Nivolumab for Resectable dMMR Endometrial Cancer - OncLive
Dr Lee on the Preliminary Safety of Nivolumab for Resectable dMMR Endometrial Cancer OncLive
Published: April 14, 2025, 6:31 p.m.
Predicting Recurrence Risk in Endometrial Cancer: A Multisequence MRI Intratumoral and Peritumoral Radiomics Nomogram Approach - Frontiers
Predicting Recurrence Risk in Endometrial Cancer: A Multisequence MRI Intratumoral and Peritumoral Radiomics Nomogram Approach Frontiers
Published: April 10, 2025, 3:24 p.m.
Neoadjuvant Nivolumab Appears Effective for Resectable, dMMR Endometrial Cancer - Oncology Nurse Advisor
Neoadjuvant Nivolumab Appears Effective for Resectable, dMMR Endometrial Cancer Oncology Nurse Advisor
Published: April 8, 2025, 4 a.m.
Dr Lee on Responses With Nivolumab in Resectable dMMR Endometrial Cancer - OncLive
Dr Lee on Responses With Nivolumab in Resectable dMMR Endometrial Cancer OncLive
Published: March 31, 2025, 10:21 p.m.
Dr Eskander on the Potential Clinical Benefit of Nivolumab in dMMR Endometrial Cancer - OncLive
Dr Eskander on the Potential Clinical Benefit of Nivolumab in dMMR Endometrial Cancer OncLive
Published: March 27, 2025, 9:23 p.m.
Link copied to clipboard!